Skip to content
10-Q

Quarterly Report

vTv Therapeutics Inc. VTVT

0001641489-25-000053

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$10.78M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$14.06M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $25.92M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $36.75M
Stockholders Equity Q2 2025 · Jun 30, 2025 $2.76M
Stockholders Equity Q2 2025 · Dec 31, 2024 $12.2M
Current Liabilities Q2 2025 · Jun 30, 2025 $5.3M
Current Liabilities Q2 2025 · Dec 31, 2024 $5.2M
Total Liabilities Q2 2025 · Jun 30, 2025 $24.04M
Total Liabilities Q2 2025 · Dec 31, 2024 $23.97M
Current Assets Q2 2025 · Jun 30, 2025 $26.37M
Current Assets Q2 2025 · Dec 31, 2024 $38.11M
Total Assets Q2 2025 · Jun 30, 2025 $26.45M
Total Assets Q2 2025 · Dec 31, 2024 $38.27M
Sga Expense Q2 2025 · Jun 30, 2025 $3.62M
Sga Expense Q2 2025 · Jun 30, 2025 $7.29M
Sga Expense Q2 2025 · Jun 30, 2024 $3.72M
Sga Expense Q2 2025 · Jun 30, 2024 $7.69M
Rd Expense Q2 2025 · Jun 30, 2025 $4.1M
Rd Expense Q2 2025 · Jun 30, 2025 $6.93M
Rd Expense Q2 2025 · Jun 30, 2024 $3.44M
Rd Expense Q2 2025 · Jun 30, 2024 $6.09M
Net Income Q2 2025 · Jun 30, 2025 −$6.05M
Net Income Q2 2025 · Jun 30, 2025 −$11.14M
Net Income Q2 2025 · Jun 30, 2024 −$5.18M
Net Income Q2 2025 · Jun 30, 2024 −$10.05M
Operating Income Q2 2025 · Jun 30, 2025 −$7.72M
Operating Income Q2 2025 · Jun 30, 2025 −$14.22M
Operating Income Q2 2025 · Jun 30, 2024 −$7.16M
Operating Income Q2 2025 · Jun 30, 2024 −$12.78M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $1M